Skip to main navigation Skip to search Skip to main content

Luteolin protect against diabetic cardiomyopathy in rat model via regulating the AKT/GSK-3β signalling pathway.

  • Yan Zhang
  • , Xiao-Qin Tian
  • , Xiang-Xin Song
  • , Jia-Pu Ge
  • , Yan-Cheng Xu*
  • *Corresponding author for this work
  • Peoples Hosp Xinjiang Uygur Autonomous Reg

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

The aim of the current investigation was to scrutinize the protective effect of luteolin against the STZ induced Diabetic Cardiomyopathy (DCM) in rats. The type II diabetes model was selected for the DCM study. In that study, we have used the low dose of the Streptozotocin (STZ) along with the high energy intake. The rats were divided into following groups viz., normal control; STZ induced DCM group, and last one corresponds to the STZ induced DCM treated with luteolin (10 mg/kg). Results of the investigation showed a reduction in fasting blood glucose level, Total Cholesterol (TC) and Triglyceride (TG) in luteolin-treated DCM rats. Moreover, the treatment group showed elevated Body Weight (BW) along with Lower Heart Weight (HW)/BW. Additionally, the luteolin-treated group rats confirmed the decrease the Interventricular Septal Diastolic Wall Thickness (IVSD), Left Ventricular Posterior Wall Thickness (LWPWT), Left Ventricular End-Diastolic Diameter (LVEDD) and increase in Heart Rate (HR). Luteolin also induced the significant improvement in the expression of GSK-3 beta and phosphorylation of Akt in the myocardium. The findings of the current study suggest that the luteolin might have a beneficial effect against DCM via improvement the Akt/GSK-3 beta signalling pathway.
Original languageEnglish
Pages (from-to)1359-1363
Number of pages5
JournalBIOMEDICAL RESEARCH-INDIA
Volume28
Issue number3
StatePublished - Jan 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Luteolin
  • Total cholesterol
  • Fasting blood glucose
  • Diabetic cardiomyopathy
  • Akt/GSK-3 beta

Indexed by

  • SCIE
  • Scopus

Fingerprint

Dive into the research topics of 'Luteolin protect against diabetic cardiomyopathy in rat model via regulating the AKT/GSK-3β signalling pathway.'. Together they form a unique fingerprint.

Cite this